Cravath and Kirkland ride pharma wave to win places on $5.8bn Abbott-Alere deal Legal Business1 February 2016Corporate and M&A Already two of the big winners from the merger bonanza in the pharmaceuticals sector, Cravath, Swaine & Moore and Kirkland & Ellis have won mandates advising on the $5.8bn purchase of diagnostic testing company Alere by Abbott Laboratories.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categoryRevolving Doors: Proskauer boosts London finance team as Paul Weiss picks up another Kirkland partnerThe law firms impressing clients with their commerciality – and what GCs wantTrading places: Freshfields makes Paul Weiss AI hire as Latham and Simpson Thacher boost corporate and finance‘For us, it all came together’ – how Proskauer built a London high yield offering in 12 monthsSlaughters, Gibson Dunn lead on Daily Mail’s £500m Telegraph Media Group acquisitionCohen & Gresser follows McDermott in eyeing up external investmentRevolving doors: Simpson Thacher, Latham, Sidley lead New Year London moves‘Seize every opportunity’ – Paul Hastings partner Reena Gogna on City law, Suits and poetryFive partners vie to succeed Hoyland as Simmons managing partner